Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
Eli Lilly terminates Sintilimab ex-China collaboration after FDA rejection
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries